Acorah Software Products - Accounts Production 14.5.601 false true 30 November 2022 1 December 2021 false 1 December 2022 30 November 2023 30 November 2023 11068370 Mr Naji Kassir Dr Hiba Al Injibar iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 11068370 2022-11-30 11068370 2023-11-30 11068370 2022-12-01 2023-11-30 11068370 frs-core:CurrentFinancialInstruments 2023-11-30 11068370 frs-core:Non-currentFinancialInstruments 2023-11-30 11068370 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2023-11-30 11068370 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2022-12-01 2023-11-30 11068370 frs-core:LandBuildings frs-core:LeasedAssetsHeldAsLessee 2022-11-30 11068370 frs-core:MotorVehicles 2023-11-30 11068370 frs-core:MotorVehicles 2022-12-01 2023-11-30 11068370 frs-core:MotorVehicles 2022-11-30 11068370 frs-core:PlantMachinery 2023-11-30 11068370 frs-core:PlantMachinery 2022-12-01 2023-11-30 11068370 frs-core:PlantMachinery 2022-11-30 11068370 frs-core:ShareCapital 2023-11-30 11068370 frs-core:RetainedEarningsAccumulatedLosses 2023-11-30 11068370 frs-bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 11068370 frs-bus:FilletedAccounts 2022-12-01 2023-11-30 11068370 frs-bus:SmallEntities 2022-12-01 2023-11-30 11068370 frs-bus:AuditExempt-NoAccountantsReport 2022-12-01 2023-11-30 11068370 frs-bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 11068370 frs-bus:Director1 2022-12-01 2023-11-30 11068370 frs-bus:Director2 2022-12-01 2023-11-30 11068370 frs-countries:EnglandWales 2022-12-01 2023-11-30 11068370 2021-11-30 11068370 2022-11-30 11068370 2021-12-01 2022-11-30 11068370 frs-core:CurrentFinancialInstruments 2022-11-30 11068370 frs-core:Non-currentFinancialInstruments 2022-11-30 11068370 frs-core:ShareCapital 2022-11-30 11068370 frs-core:RetainedEarningsAccumulatedLosses 2022-11-30
Registered number: 11068370
Dermasurge Limited
Financial Statements
For The Year Ended 30 November 2023
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 11068370
2023 2022
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 1,220,876 1,277,696
1,220,876 1,277,696
CURRENT ASSETS
Debtors 5 29,932 28,901
Investments 6 201,373 -
Cash at bank and in hand 165,043 341,718
396,348 370,619
Creditors: Amounts Falling Due Within One Year 7 (751,634 ) (642,791 )
NET CURRENT ASSETS (LIABILITIES) (355,286 ) (272,172 )
TOTAL ASSETS LESS CURRENT LIABILITIES 865,590 1,005,524
Creditors: Amounts Falling Due After More Than One Year 8 (1,044,956 ) (1,245,000 )
NET LIABILITIES (179,366 ) (239,476 )
CAPITAL AND RESERVES
Called up share capital 9 100 100
Profit and Loss Account (179,466 ) (239,576 )
SHAREHOLDERS' FUNDS (179,366) (239,476)
Page 1
Page 2
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Naji Kassir
Director
15/10/2024
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Dermasurge Limited is a private company, limited by shares, incorporated in England & Wales, registered number 11068370 . The registered office is 121 Harley Street Harley Street, London, United Kingdom, W1G 6AX.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Revenue represents amounts receivable for general and cosmetic dermatology, and are recognised upon completion of the services.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Leasehold Over useful life of lease
Plant & Machinery 25% straight line
Motor Vehicles 25% reducing balance
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 6 (2022: 5)
6 5
Page 3
Page 4
4. Tangible Assets
Land & Property
Leasehold Plant & Machinery Motor Vehicles Total
£ £ £ £
Cost
As at 1 December 2022 1,314,277 189,207 48,440 1,551,924
Additions - 2,481 - 2,481
As at 30 November 2023 1,314,277 191,688 48,440 1,554,405
Depreciation
As at 1 December 2022 129,751 130,187 14,290 274,228
Provided during the period 27,518 23,246 8,537 59,301
As at 30 November 2023 157,269 153,433 22,827 333,529
Net Book Value
As at 30 November 2023 1,157,008 38,255 25,613 1,220,876
As at 1 December 2022 1,184,526 59,020 34,150 1,277,696
5. Debtors
2023 2022
£ £
Due within one year
Trade debtors (741 ) 150
Other debtors 30,673 28,751
29,932 28,901
6. Current Asset Investments
2023 2022
£ £
Short term deposits 201,373 -
The short term deposit relates to a fixed deposit of £200,000. The deposit has a term of 94 days, maturing on 5 February 2024, with an interest rate of 4.32% per annum.
7. Creditors: Amounts Falling Due Within One Year
2023 2022
£ £
Trade creditors 36,960 14,220
Bank loans and overdrafts 3,781 -
Other creditors 671,603 616,490
Taxation and social security 39,290 12,081
751,634 642,791
Page 4
Page 5
8. Creditors: Amounts Falling Due After More Than One Year
2023 2022
£ £
Bank loans 1,044,956 1,245,000
The bank loan is secured by a first legal charge over the company’s leasehold property and a floating charge secured over the company’s plant, machinery, furniture and equipment. The loan is repayable on 31 December 2027 and interest is charged at a rate of 2.5%.
9. Share Capital
2023 2022
£ £
Allotted, Called up and fully paid 100 100
10. Related Party Transactions
Naji Kassir and Dr. Hiba Al InjibarDirectorsAs of balance sheet date, the company owed £423,257 (2021: £426,785) to both directors. The loans are interest free and have no set repayment date.

Naji Kassir and Dr. Hiba Al Injibar

Directors

As of balance sheet date, the company owed £423,257 (2021: £426,785) to both directors. The loans are interest free and have no set repayment date.

Page 5